Skip to main content
Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.500
+0.020 (1.35%)
At close: Jun 26, 2026, 4:00 PM EDT
1.475
-0.025 (-1.65%)
After-hours: Jun 26, 2026, 5:21 PM EDT

Coherus Oncology Employees

Coherus Oncology had 147 employees as of December 31, 2025. The number of employees decreased by 81 or -35.53% compared to the previous year.

Employees
147
Change (1Y)
-81
Growth (1Y)
-35.53%
Revenue / Employee
$323,331
Profits / Employee
$1,284,593
Market Cap
231.37M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025147-81-35.53%
Dec 31, 2024228-78-25.49%
Dec 31, 2023306-53-14.76%
Dec 31, 2022359278.13%
Dec 31, 2021332154.73%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Karyopharm Therapeutics 228
Fate Therapeutics 161
Codexis 146
Keros Therapeutics 87
Camp4 Therapeutics 48
Protara Therapeutics 46
Anavex Life Sciences 34
Whitehawk Therapeutics 29
Employee Rankings

CHRS News

More News